Medical Device Private Equity: Returns, Access, and Risk
Medical device private equity sits at an intersection that most asset classes cannot replicate: durable demographic tailwinds, high regulatory barriers that protect incumbents, and strategic acquirer premiums that routinely run 30-50% above what financial buyers pay. According to Grand View Research